If drug prices continue to rise at current rates without Medicare coverage changes, more than 1.1 million seniors are projected to die over the coming decade because they skip medications due to costs, according to a study by West Health Policy Center and Xcenda, the research arm of the drug distributor AmerisourceBergen. Medicare negotiation of drug prices in the form of House Democrats’ H.R. 3 would prevent 94,000 deaths annually from beneficiaries not taking their pills, according to the report...